CSF profiles of angiogenic and inflammatory factors depend on the respiratory status of ALS patients

References

• Lyall RA, Donaldson N, Polkey MI, Leigh PN, Moxham J. Respiratory muscle strength and ventilatory failure in amyotrophic lateral sclerosis. Brain 2001; 124: 2000–13
   PubMed Web of Science ®Google Scholar
• Oosthuyse B, Moons L, Storkebaum E, Beck H, Nuyens D, Brusselmans K. Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration. Nat Genet 2001; 28: 131–8
   PubMed Web of Science ®Google Scholar
• Xie Y, Weydt P, Howland DS, Kliot M, Möller T. Inflammatory mediators and growth factors in the spinal cord of G93A-SOD1 rats. Neuroreports 2004; 15: 2513–6
   PubMed Web of Science ®Google Scholar
• Wang Y, Mao XO, Xie L, Banwait S, Marti HH, Greenberg DA, et al. Vascular endothelial growth factor overexpression delays neurodegeneration and prolongs survival in amyotrophic lateral sclerosis mice. J Neurosci 2007; 27: 304–7
   PubMed Web of Science ®Google Scholar
• Lemmens R, van Hoecke A, Hersmus N, Geelen V, D'Hollander I, Thijs V, et al. Overexpression of mutant SOD1 causes a motor axonopathy in the zebrafish. Hum Mol Gen 2007; 16: 2359–35
   PubMed Web of Science ®Google Scholar
• Li B, Xu W, Luo C, Gozal D, Liu R. VEGF induced activation of the PI3 K/Akt pathway reduces mutant SOD1-mediated motor neuron cell death. Brain Res Mol Brain Res 2003; 111: 155–64
   PubMedGoogle Scholar
• van den Bosch L, Storkebaum E, Vleminckx V, Moons L, Vanopdenbosch L, Scheveneels W, et al. Effects of VEGF 165 on motor neuron degeneration. Neurobiology of Disease 2004; 17: 21–8
   PubMed Web of Science ®Google Scholar
• Tolosa L, Mir M, Asensio VJ. Vascular endothelial growth factors protect spinal cord motor neurons against glutamate induced excitotoxicity via phosphatidyl inositol 3 kinase. J Neurochem 20008; 105: 1080–90
   Google Scholar
• Azzouz M, Ralph GS, Storkebaum E, Walmsley LE, Mitrophanous KA, Kingsman SM, et al. VEGF delivery with retrogradely transported lentivector prolongs survival in a mouse ALS model. Nature 2004; 429: 413–7
   PubMed Web of Science ®Google Scholar
• Zheng C, Nennesmo I, Fadeel B, Henter JI., Vascular endothelial growth factor prolongs survival in a transgenic mouse model of ALS. Ann Neurol 2004; 56: 564–7
   PubMed Web of Science ®Google Scholar
• Storkebaum E, Lambrechts D, Dewerchin M, Moreno-Murciano MP, Appelmans S, Oh H, et al. Treatment of motor neuron degeneration by intracerebroventricular delivery of VEGF in a rat model of ALS. Nat Neurosc 2005; 1: 85–92
   Google Scholar
• Tovary-y-Romo LB, Zepeda A, Tapia R. Vascular endothelial growth factor prevents paralysis and motor neuron death in a rat model of excitotoxic spinal cord neurodegeneration. J Neuropathol Exp Neurol 2007; 66: 913–22
   PubMed Web of Science ®Google Scholar
• Sathasivam, S. VEGF and ALS. Neurosci Res. 2008, Jul 9. (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Lambrechts, D, Poesen, K, Fernández-Santiago, R, Al-Chalabi, A, del Bo, R, van Vught, PW, , et al Meta-analysis of VEGF variations in ALS: increased susceptibility in male carriers of the –2578AA genotype. J Med Genet. 2008, Jul 17. (Epub ahead of print).
   PubMed Web of Science ®Google Scholar
• Greenway MJ, Andersen PM, Russ C, Ennis S, Cashman S, Donaghy C, et al. ANG mutations segregate with familial and sporadic amyotrophic lateral sclerosis. Nat Genet 2006; 38: 411–3
   PubMed Web of Science ®Google Scholar
• Cronin S, Greenway MJ, Ennis S, Kieran D, Green A, Prehn JH, et al. Elevated serum angiogenin levels in ALS. Neurology 2006; 67: 1833–6
   PubMed Web of Science ®Google Scholar
• Crabtree B, Thiyagarajan N, Prior SH, Wilson P, Iyer S, Ferns T, et al. Characterization of human angiogenin variants implicated in amyotrophic lateral sclerosis. Biochemistry 2007; 46: 11810–8
   PubMed Web of Science ®Google Scholar
• Subramanian V, Crabtree B, Acharya KR. Human angiogenin is a neuroprotective factor and amyotrophic lateral sclerosis associated angiogenin variants affect neurite extension/pathfinding and survival of motor neurons. Hum Mol Genet 2008; 17: 130–49
   PubMed Web of Science ®Google Scholar
• Bicknell R, Vallee BL. Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2. Proc Natl Acad Sc 1989; 86: 1573–7
   PubMed Web of Science ®Google Scholar
• Soncin F. Angiogenin supports endothelial and fibroblast cell adhesion. Proc Natl Acad Sc 1992; 89: 2232–6
   PubMed Web of Science ®Google Scholar
• Chavez JC, Baranova O, Lin J, Pichiule P. The transcriptional activator hypoxia inducible factor-2 (HIF-2/EPAS) regulates the oxygen dependent expression of erythropoietin in cortical astrocytes. J Neurosci 2006; 37: 9471–81
   Google Scholar
• Pichiule P, La Manna JC. Angiopoietin-2 and rat brain capillary remodelling during adaptation and de-adaptation to prolonged mild hypoxia. J Appl Physiol 2002; 93: 1131–9
   PubMed Web of Science ®Google Scholar
• La Manna J, Chavez J, Pichiule P. Review of structural adaptation to hypoxia in the rat brain. The Journal of Experimental Biology 2004; 207: 3163–9
   PubMed Web of Science ®Google Scholar
• Pichiule P, Chavez JC, La Manna JC. Hypoxic regulation of angiopoietin-2 expression in endothelial cells. Journal of Biology and Chemistry 2004; 13: 12171–80
   Google Scholar
• Lukiw WJ, Ottlecz A, Lambrou G, Grueninger M, Finley J, Thompson HW, et al. Coordinate activation of HIF-1 and NF-kappaB DNA binding and COX-2 and VEGF165 expression in retinal cells by hypoxia. Invest Ophtalmol Vis Sci 2003; 44: 4163–70
   PubMed Web of Science ®Google Scholar
• Guénard, H, Rouabis, S. Physiological aspects of the decline of pulmonary function with age. Rev Mal Resp. 2002;19:230–40, (In French.)
   PubMed Web of Science ®Google Scholar
• Hukins CA, Hillman DR. Daytime predictors of sleep hypoventilation in Duchenne muscular dystrophy. Am J Respir Crit Care Med 2000; 161: 166–70
   PubMed Web of Science ®Google Scholar
• Just N, Moreau C, Lassalle P, Gosset P, Perez T, Brunaud-Danel V, et al. High erythropoietin and low levels of VEGF165 in CSF from ALS patients suggest an abnormal response to hypoxia. Neuromuscular Disorders 2007; 17: 169–73
   PubMed Web of Science ®Google Scholar
• Boillée S, Yamanaka K, Lobsiger CS, Copeland NG, Jenkins NA, Kassiotis G, et al. Onset and progression of inherited ALS determined by motor neurons and microglia. Science 2006; 312: 1389–92
   PubMed Web of Science ®Google Scholar
• Moreau C, Devos D, Brunaud-Danel V, Defebvre L, Perez T, Destée A, et al. Paradoxical response of VEGF165 expression in CSF to hypoxia in ALS patients. J Neurol Neurosurg Psychiatry 2006; 77: 255–7
   PubMed Web of Science ®Google Scholar
• Zhong Z, Deane R, Ali Z, Parisi M, Shapovalov Y, O'Banion MK, et al. ALS causing SOD1 mutants generate vascular changes prior to motor neuron degeneration. Nature Neurosc. 2008; 11: 420–2
   PubMed Web of Science ®Google Scholar
• Garbuzova-Davis, S, Saporta, S, Haller, E, Kolomey, I, Bennett, SP, Potter, H, Sanberg, PR. Evidence of compromised blood-spinal cord barrier in early and late symptomatic SOD 1 mice modelling ALS. PLoS ONE. 2007, Nov 21; 2(11):e1205.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Sakurai M, Abe K, Sadahiro M, Tabayashi K, Itoyama Y. Expression of angiogenic factors in rabbit spinal cord after transient ischaemia. Neuropathol Appl Neurobiol 1999; 25: 63–71
   PubMed Web of Science ®Google Scholar